, Cu(I) is coordinated to three histidines, as indicated by X-ray absorption data, and Cu(II) to three histidines and one or two water molecules. Both ions are bound in the interior of the three-stranded coiled coils with affinities that range from nano-to micromolar [Cu(II)], and picomolar [Cu(I)]. The Cu (His) 3 active site is characterized in both oxidation states, revealing similarities to the Cu T2 site in the natural enzyme. The species Cu(II) (TRIL23H) 3 2+ in aqueous solution can be reduced to Cu(I)(TRIL23H) 3 + using ascorbate, and reoxidized by nitrite with production of nitric oxide. At pH 5.8, with an excess of both the reductant (ascorbate) and the substrate (nitrite), the copper peptide Cu(II)(TRIL23H) 3
2+
acts as a catalyst for the reduction of nitrite with at least five turnovers and no loss of catalytic efficiency after 3.7 h. The catalytic activity, which is first order in the concentration of the peptide, also shows a pH dependence that is described and discussed.
NiR | NO | TRI peptides
M
etalloproteins are involved in the most complex biomolecular processes in nature. De novo designed metallopeptides provide an approach for constructing metalloenzymes that reproduce the structure and function of native systems (1, 2) . Three important examples of functional, de novo designed enzymes are the Dueferri, MID1-zinc, and zinc(II) TRI systems. The first uses Fe bound to a four-helix bundle in a redox role to oxidize phenols (3, 4) , whereas the other two contain zinc(II) in a (His) 3 environment and are models for carbonic anhydrase (5, 6) . The zinc(II) TRI system, in particular, exploits Zn(II) to mimic very well the active site structure and CO 2 -hydrolytic chemistry of the native enzyme, using three-stranded coiled coils (6) . Among de novo designed systems, those containing redox active metal centers are most challenging as one must account for the coordination environment in two distinct oxidation levels.
Copper enzymes are extraordinarily efficient molecular tools carrying out many reactions, including biological denitrification (7) (8) (9) , in which anaerobic bacteria use nitrogen oxide species as terminal electron acceptors in place of dioxygen. This pathway is crucial for returning fixed nitrogen to the atmosphere, thereby completing the terrestrial nitrogen cycle (7) (8) (9) . Copper nitrite reductase [NiR; Achromobacter cycloclastes (AciNiR) or Alcaligenes xylosoxidans (AxNiR) among the most studied] is a homotrimeric metalloenzyme that contains both type 1 and type 2 copper sites, carrying out dissimilatory reduction of nitrite to nitric oxide (7, 8, 10, 11) . The type 2 copper, at which the catalytic conversion of nitrite into nitric oxide occurs (NO 2 − + e − + 2H + = NO + H 2 O), is coordinated to three imidazoles and a water molecule, forming a distorted tetrahedral environment (12) . The electron necessary for the reduction of nitrite is provided by the type 1 copper (10).
Examples of Cu(I) (13, 14) and Cu(II) de novo designed helix bundles have been reported (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) . However, only a few examples of controlled binding of copper at (His) 3 sites are known (17, 20, 21) . Although Cu(I)/(II) redox processes were presented for a few systems (13, 14, 22) , none was fully characterized in both oxidation states, which is essential for catalytic copper redox protein designs. We felt that Cu(TRIL23H) 3 n+ [TRIL23H = (Ac-G[LKALEEK] 3 [HKALEEK]G-NH 2 )] was an ideal system to cycle between Cu(I) and Cu(II), because an X-ray crystal structure of Zn(II) bound to three histidines in the related peptide Hg S Zn N (CSL9CL23H) 3 + was known ( Fig. 1 ) (6) , which suggests that the histidine residues might bind to Cu(I) in a way similar to that found in Zn(II). Herein, we explore the reactivity of both Cu(I)(TRIL23H) 3 + and Cu(II)(TRIL23H) 3 2+ metallopeptides as NiR models and demonstrate that these systems are the most effective artificial systems for catalytic nitrite reduction in aqueous solution.
Results
Characterization of Cu(I) and Cu(II) Sites. In the pH range 6-7.4, only two singlets (∼7.0 and 7.7 ppm) are observed in D 2 O for apo-(TRIL23H) 3 , corresponding to the three equivalent His H δ and H e protons, respectively. The addition of 1 eq of [Cu(I)(CH 3 CN) 4 ] BF 4 to apo-(TRIL23H) 3 at pH 6 or pH 7.4 leads to changes in the NMR spectra with the appearance of multiple peaks in the range 6.6-8.7 ppm (Fig. S1 A-D) . Although the spectra at these two pH values are different, possibly because of a slight change of the geometry of the (His) 3 site, they prove the Cu(I) coordination to the imidazole nitrogens. The presence of multiple peaks in the spectra of Cu(I)(TRIL23H) 3 + is likely the result of the presence of different similar energy conformations at the Cu(I)(His) 3 site, an observation consistent with what was observed for the Cu(I) adduct of the 1-42 fragment of β-amyloid (25). Importantly, given the 1:1 Cu(I):(TRIL23H) 3 stochiometry of these experiments, the formation of two-stranded Cu(I)(TRIL23H) 2 + is ruled out by the absence of residual signals for the apo-peptide. The pH-(TRIL2WL23H) 3 (Fig. S2A) show a resolved 1s→4p transition at ∼8,984 eV, characteristic of three-coordinate complexes (27). The spectra for Cu(I)(TRIL2WL23H) 3 at pH 5.9 and 7.4 are indistinguishable, demonstrating that the Cu(I) structure is independent of pH over this range. The extended X-ray absorption fine structure (EXAFS) spectra for Cu(I)(TRIL2WL23H) 3 ( Fig.  S2 B and C) show peaks for both nearest-neighbor scattering and outer-shell scattering characteristic of imidazole ligation. The nearest-neighbor scattering has an amplitude consistent with three low-Z ligands, with an apparent Cu-(N/O) distance of 1.93 Å, as expected for a three-coordinate Cu(I) site. The nearestneighbor and outer-shell scatterings are well modeled by using three imidazoles modeled as rigid groups with only a variable Cu-N distance and Debye-Waller factors proportional to those calculated ab initio (28). Inclusion of an additional shell to model a putative water ligand did not improve the fit. This, together with the XANES evidence for a three-coordinate Cu(I) and the relatively short Cu-N distance, all point to a Cu(I) that is ligated only to the three histidine ligands. The fitted Debye-Waller factor for the Cu-N shell is large (∼9 × 10 −3 Å 2 ), suggesting that the site is distorted, as is often seen for three-coordinate Cu(I) sites. Assuming that the dynamic Debye-Waller factor is ∼4 × 10
, as seen in model compounds, the observed value implies a spread in distances of ∼0.1-0.15 Å (Table S1) .
We next characterized the Cu(II)(TRIL23H) 3 2+ using visible spectroscopy. From pH 5.8-7.4, a broad absorption maximum at 640 nm (e 640 nm = 133-138 M −1 cm
) assigned to Cu(II) d-d transitions is observed (Table S2) . Similarily, Cu(II)(TRIL2WL23H) 3
2+
presents similar molar absorbance values in the same pH range (Table S2 ). The absorption maxima are consistent, for both peptides, with a Cu(II)(His) 3 site that might contain either one or two exogenous water ligands (predicted λ max of 634 ± 11 nm) (29). These observations prove the existence of the Cu(II)(His) 3 site in this pH region and eliminate a Cu(II)(His) 2 site for which a λ max ∼690 nm is expected (29).
The EPR spectra of both Cu(II)(TRIL23H) 3 2+ and Cu(II) (TRIL2WL23H) 3 2+ have features typical of type 2 copper centers (Fig. S3) , and for the latter, the spectra do not change significantly in the pH range 5.19-7.80. The observed g values (g // = 2.27) and hyperfine coupling constant (A // = 186 G and 188 G for the two peptides, respectively) are somewhat larger than those observed for NiR in which a Cu(His) 3 (OH 2 ) site is present (10, 30) . These parameters are more consistent with a five-coordinate structure Cu(His) 3 (OH 2 ) 2 (31, 32), with a distorted square pyramidal geometry containing three quasi-in-plane imidazoles, as suggested by the observed d-d transition at 640 nm. Upon addition of nitrite (27 eq) to Cu(II)(TRIL23H) 3
, a 9-G decrease of the A // , from 186 to 177 G, was observed (Fig. S3) , whereas no further changes were observed for addition of nitrite up to 212 eq. Interestingly, a similar 13-G decrease in the A // was observed for Rhodobacter sphaeroides NiR upon addition and binding of nitrite, supporting the hypothesis of the direct binding of nitrite to the copper center in Cu(II)(TRIL23H) 3 2+ (10). (Fig. S4 ). The titration was also carried out using Cu(NO 3 ) 2 to evaluate the role of anions in the binding of Cu(II) to (TRIL2WL23H) 3 , resulting in a K d of 2.0 (3) μM at pH 5.9 and 6.4 (1.9) nM at pH 7.4. The dissociation constants for Cu(I)(TRIL2WL23H) 3 + were determined by visible competitive titrations using bathocuproine disulfonate as the competing ligand for Cu(I) (K d = 3.1 (7) and 0.20 (6) pM at pH 5.9 and 7.4, respectively; Fig. S4 ) (33). The calculated reduction potential for Cu(II)(TRIL2WL23H) 3 2+ at pH 5.9 is 400 (30) mV using Cl − as an anion and 500 (30) mV using NO 3 − as an anion. At pH 7.4, the potential is 430 (30) mV for both anions.
The reduction of Cu(II)(TRIL23H) 3 2+ by addition of a stoichiometric amount (1 eq, 0.5 mol) of ascorbate can be obtained within the mixing time ( Fig. 2A) . Although samples of Cu(II)(TRIL23H) 3
reduced with sodium ascorbate did not undergo reoxidation for 24 h when stored in a sealed cuvette, the visible band at 640 nm reappeared after the solutions were exposed to air. NiR Activity. We assessed the capability of nitrite to oxidize Cu(I)(TRIL23H) 3 2+ generated in situ using ascorbate. The 640-nm absorbance of Cu(II)(TRIL23H) 3 2+ increased over time in samples containing a 100-fold excess of nitrite ( Fig. 2 B and C) . At pH 5.8, the recovery of 77% of the initial absorbance is obtained in 70 min. Although the recovery of 100% of the initial absorbance was not achieved, successive additions of ascorbate to the same sample allowed reduction-reoxidation cycles of the Cu(II)(TRIL23H) 3 2+ sample for another three additions of reductant, with absorbance recoveries of over 65% of the initial absorbance (Fig. S5) .
The production of NO by reacting Cu(I)(TRIL23H) 3 + with 1 eq of nitrite at pH 5.8 was demonstrated by visible spectroscopy by trapping the evolved gas as the colored [Fe(NO)(EDTA)] 2− complex (Fig. S6) (34) . More importantly, the production of NO was observed at pH 5.8 using both Cu(I)(TRIL23H) 3 + and ascorbatereduced Cu(II)(TRIL23H) 3
. For these two samples, the amount of trapped NO is 71% and 48% after 1 h, respectively, of that from a control sample containing [Cu(I)(CH 3 CN) 4 ]
We tested whether our system carries out NiR activity under catalytic conditions (C Asc = 1.15 mM, C nitrite = 30 mM, C metallopeptide = 0.180 mM). In this assay, the oxidation of ascorbate as sacrificial reductant was monitored spectrophotometrically by observing the decrease of its absorption band centered at 265 nm (Fig. 3A) . The quantity of ascorbate oxidized in 175 min at pH 5.9, corrected for the background reaction, corresponds to 1.5 (2) times the moles of Cu(II)(TRIL23H) 3
and, therefore, results in a turnover number of 3.0 when expressed as moles of electrons per mole of Cu(II)(TRIL23H) 3
. Moreover, five turnovers have been measured at pH 5.8 in 220 min (Fig. 3B) . The rate of the background reaction of ascorbate with nitrite is not influenced by the presence of either traces of Cu(II) ion (0.21 μM) or apo-(TRIL23H) 3 (0.90 mM, Fig. S7A ), and ascorbate is stable in the absence of nitrite (Fig. S7A) . The oxidation rate of the ascorbate also depends on the concentration of Cu(II)(TRIL23H) 3 2+ , with a linear increase observed for increasing metallopeptide concentrations (0.171-0.513 mM, Fig. S7 B and C). These observations suggest that ascorbate acts as a sacrificial reductant for Cu(II)(TRIL23H) 3 2+ , and that the Cu(I)(TRIL23H) 3 + species is catalytically active in reducing nitrite to NO. Moreover, by FTIR analysis of the headspace gas, we also proved that no N 2 O is produced under catalytic conditions (SI Experimental Procedures).
Both the kinetics of oxidation of Cu(I)(TRIL23H) 3 + (through the recovery of absorbance at 640 nm) and of ascorbate (through the decrease of absorbance at 265 nm) were studied as a function of pH. The initial rate of reoxidation of Cu(I)(TRIL23H) 3 + (v Cu,ox ) was studied between pH 5.8 and 7.4. Although the initial increase of absorbance at 640 nm is large at pH 5.8, at pH 7.0 this absorption is very small and at pH 7.4 we did not observe any significant increase of absorbance in 2 h (Fig. S8A) . The pseudo-firstorder rate constants
determined from the initial rates (12 min) as a function of pH are reported in Table 1 and in Fig. 4A and Fig. S8 . The rate of oxidation of ascorbate in the presence of Cu(I)(TRIL23H) 3 + and nitrite (v Asc,ox ) was studied in the pH range 5.3-6.5. The initial rate of the reaction 1/2Asc − + Cu(II)(TRIL23H) 3 2+ = 1/2dH-Asc + Cu(I)(TRIL23H) 3 + + 1/2H + decreases with increasing pH, as shown in ]) as a function of pH are reported in Table  1 and Fig. 4 .
Discussion
Several copper complexes with nitrogen ligands as mimics for the type 2 copper site of NiR were synthesized in recent years (9, 35, 36) . They have extensively expanded our understanding of the structures as well as the mechanisms of native copper NiR. Nevertheless, almost all the synthetic models are soluble only in organic solvents. The study of copper NiR itself is complicated by having two distinct copper centers with different functions and physical properties. De novo designed metallopeptides are soluble in water, can enforce lower metal coordination numbers, and inhibit dimerization reactions while providing a hydrophobic environment that contains a single metal cofactor at which the desired chemistry may be performed. In a recent study, we showed that a de novo design strategy is highly effective for providing mimics of carbonic anhydrase using a mononuclear Zn(II)-based hydrolytic system (6) . In this report, we explore the more challenging objective of obtaining a de novo designed redox-based assembly that carries out a reaction similar to that at the Cu T2 site in NiR.
Because both Zn(II) and Cu(I) are d 10 metals, we felt that the latter ion could be bound similarly to Zn(II) in the same (His) 3 site found in Hg S Zn N (CSL9CL23H) 3 + , as recently reported (6) . A comparison of this Zn(II) site to that of type 2 Cu(II) in CuNiR [R. sphaeroides NiR, Protein Data Bank (PDB) ID code 2DY2] is shown in Fig. 1 . The overlayed metal sites show that the metal ion environments are well matched and, in both structures, the metal ions are coordinated to the imidazole N e with a water molecule occupying the fourth coordination position, as observed in NiR.
To test this hypothesis, we subjected the Cu n+ (TRIL23H) 3 n+ system to multiple spectroscopic methods. Our NMR data on Cu(I)(TRIL23H) 3 + and XANES and EXAFS data on Cu(I)(TRIL2WL23H) 3 + indicate that all three histidine imidazoles are coordinated to Cu(I) above pH 4.8. These observations suggest that Cu(I) has a three-coordinate distorted trigonal planar geometry within the coiled coils. Our visible and EPR data also confirm the presence of a Cu(II)(TRIL23H) 3
2+
, where Cu(II) has parameters for a type 2 copper center, suggesting a tris-histidine set of protein ligands. However, in NiR, Cu(II) is four-coordinate, whereas the EPR spectra of Cu(II)(TRIL23H) 3 2+ indicate that the Table 1 . Pseudo-first-order rate constants for the oxidation of Cu(I)(TRIL23H) 3 + (k first,Cu ) and of oxidation of ascorbate (k first,Asc ) as a function of the pH (C Nitrite = 30 mM)
center likely is five-coordinate. We also have shown that this peptide possesses a good to high affinity for both oxidation states of copper. The affinity for Cu(I) in particular, which is in the nanomolar range, is remarkably close to that found for the Nterminal fragment 1-14 of human copper transporter hCtr1, which contains three histidine residues (∼0.16 pM) (37) and much higher than that of amyloid β 1-42 (∼50 nM) (38).
On the basis of these stability constants, we calculated a reduction potential for Cu(II)(TRIL23H) 3 2+ of ∼400-500 mV (pH 5.9 and pH 7.4 for both chloride and nitrate as counteranions). This value is higher than those measured for type 2 copper centers in NiR, which have been reported to be 218 mV at pH 6.0 and 137 mV at pH 8.4 for R. sphaeroides (12) , or in the range 220-310 mV at pH 7.0 for A. cycloclastes and A. xylosoxidans (39). One possible explanation for this relatively high reduction potential for Cupeptide is that Cu(I) is strongly stabilized by its distorted trigonal planar structure. In addition, the coordination number changes from three to five [as shown in the EXAFS data for Cu(I) and EPR and UV-visible data for Cu(II)], leading to the change of geometry of the site, creating a relatively large energy barrier for oxidation. In native enzymes, Cu T2 sites are coupled with either a Cu T1 site or other cofactors to function. In particular, a Cu(His) 3 site is involved in electron transfer (peptidylglycine α-hydroxylating monooxygenase) (40), in dioxygen activation (amine oxidase) (41), or nitrite reduction (NiR) (42). Although the potential of the Cu T1 sites in native proteins spans from 350 to 790 mV (43, 44), those of Cu T2 sites are lower. For example, the potential of Cu T2 site in laccase (extracted from Rhus vernicifera), is one of the highest (390 mV at pH 7.4), but still lower than that of our construct (45).
Although higher than those of NiRs, these reduction potentials suggested that Cu(I)(TRIL23H) 3 + would have NiR activity [formal E 0 of nitrite ∼1.3 V at pH 6.0 (7)]. Therefore, we assessed the reactivity of Cu(II)(TRIL23H) 3 + with nitrite. Because the reduction potential of ascorbate in the pH range 5-7 is ∼100 mV, we expected that Cu(II)(TRIL23H) 3 2+ could be quantitatively reduced to Cu(I)(TRIL23H) 3 + by the addition of sodium ascorbate. The bleaching of the 640-nm d-d band occurred within the mixing time, which confirmed this prediction. Thus, a reduced metallopeptide could be formed in situ, which prompted us to investigate the NiR activity of Cu(I)(TRIL23H) 3 + by assessing the production of NO and the possibility of cycling between the Cu(II) and Cu(I) forms of the metallopeptide in the presence of Asc − as the reductant and NO 2 − the oxidant. The production of nitric oxide and the oxidation to the Cu(II) form of the metallopeptide may be observed by reacting Cu(I)(TRIL23H) 3 + with nitrite. It is worth mentioning that the detected NO production is expected to be less than quantitative, as loss of NO due to system leaks and possible reactions involving NO as a radical will diminish the total amount of NO produced. However, these results demonstrate that both the oxidized metal site and NO are products of the reaction of Cu(I)(TRIL23H) 3 + with nitrite. These data in concert demonstrate that we have made a functional mimic of the NiR copper type 2 center.
The spectrophotometric data for the ascorbate oxidation reaction allowed us to establish that Cu(II)(TRIL23H) 3 2+ undergoes five turnovers, expressed as moles of electrons per moles of Cu(II). As the reduction of Cu(II) into Cu(I) occurs within seconds after the addition of ascorbate, the turnover number of five corresponds to five nitrite ions reduced after 220 min. No catalyst decomposition is observed as the progress curve for absorbance vs. time remains in the linear regime throughout the 220-min reaction time. Hence, the turnover number is limited by the electron donor concentration rather than by the catalyst stability (Fig. 3B) .
Both the rate of oxidation of ascorbate and the reoxidation of Cu(I)(TRIL23H) 3 + have been found to be pH dependent. Moreover, the rate constants for the oxidation of ascorbate by Cu(II)(TRIL23H) 3 2+ (k first,Asc , Table 1 and Fig. 4A ) under catalytic conditions match the first-order rate constants k first,Cu for the oxidation of Cu(I)(TRIL23H) 3 + by nitrite (both k first values refer to samples containing 30 mM nitrite) reasonably well. This demonstrates that the electron transfer from Cu(I)(TRIL23H) 3 + to nitrite with the formation of Cu(II)(TRIL23H) 3 2+ is the rate-detemining step of the overall catalytic process, and rules out the possibility of ascorbate consumption by the formed NO, which should lead to the observed values for k first,Asc significantly larger than those of k first,Cu . We believe that the reasons for this pH dependence do not stand, as found for the enzyme NiR, in the deprotonation of a coordinated water molecule at the Cu(II)(His) 3 site, as both the visible absorption and the EPR spectra do not show significant changes in the pH range 5.2-7.4 (Table S2 , Fig. S3 ) (12, 46) . More likely, this pH dependence is the result either of some changes at the Cu(I)(His) 3 3 site in aqueous solution, thus representing a highly advanced model of NiR. It is clear from the pH profile that higher activities can be achieved at even lower pH, although these rates are still not competitive with NiR. Numerous other mononuclear models that examine NiR reactivity have been explored so far (31, 36, 47-50). These compounds are split into those whose activities have been investigated in nonaqueous solutions (34, 49, 50) and those that have been examined in aqueous solutions (47, 48, 51-54). In the case of nonaqueous systems, the reaction rates are higher than those observed in aqueous solutions, and the ligands in some cases model the tris-His environment of NiR relatively well (9, 49, 50) . Although the nonaqueous conditions allowed the number of water molecules bound to copper to be controlled, the use of these complexes does not account for several features of the NiR reaction, such as the different dielectrics between the exterior and the enzyme pocket and the hydrogen bonding that occurs in aqueous conditions. There are only a few examples of functional copper complexes that can reduce nitrite in aqueous solutions, and in general these systems have far lower rates that those observed in nonaqueous conditions. In some cases, these complexes produced N 2 O rather than NO (48, 54), whereas the systems in which multiple turnovers were observed have been associated mostly with electrocatalytic reactions, particularly heterogeneous systems (i.e., catalyst linked to the electrode surface) (47, 48, 51, 54). One example has been reported of a copper complex capable of at least four turnovers in 15 min when reduced using photoactivated [Ru(II)(bpy) 3 ] 2+ as the electron donor, but with a significant decrease in activity (NO generation) after two turnovers (52). The present chemistry advances the field in the following ways: we provide a reasonable, although not exact, structural model for both Cu(I) and Cu(II) for NiR, which has NiR activity in aqueous solution and an almost selective production of NO. Although our rates are modest, especially compared to native enzymes, we do see multiple turnovers under homogeneous conditions, with rates that are 10 times faster than those previously observed for a homogeneous electroreduced complex [k cat = 5.4 × 10
at pH 5.5 (47)]. Moreover, when the latter complex is linked to an electrode surface or photoreduced, faster rates have been observed but at the expense of the stability of the catalyst (47, 51-53). In contrast, our data reveal that our catalyst is robust and carries out multiple turnovers with no decrease in efficiency. Equally important, the product of our reaction is dominantly NO as opposed to other homogeneous catalysts, which also form N 2 O (48, 54). The latter point may reflect the steric constraints and the proper matching of the coordination geometry for Cu(I) and Cu(II) in our system.
Experimental Procedures
General Procedures. All samples containing Cu(I) were handled in the glove box using oxygen-free water or buffered aqueous solutions. The procedures for sample preparation, chemical compounds used, and instrumentation are given in SI Experimental Procedures.
Peptide Synthesis and Purification. TRIL23H and TRIL2W23H (Ac-GWKALEEK [LKALEEK] 2 HKALEEKG-NH 2 ) were synthesized on an Applied Biosystems 433A peptide synthesizer using standard protocols (55) and purified and characterized as reported (56). Solutions of the apo-peptides were prepared by weight in doubly distilled water or in buffered solutions where appropriate.
NMR Spectroscopy. Samples of apo-(TRIL23H) 3 X-Ray Absorption Spectroscopy. A 1-mM Cu(I)(TRIL2WL23H) 3 solution was made in the glove box with 50 mM degassed MES buffer. Excess apo-peptide (1 mM) was added to ensure the free Cu(I) concentration was minimum (<0.01% total copper concentration). The samples were mixed with 50% glycerol as a glassing agent, loaded into a sample cell, and frozen in liquid nitrogen. Measurements were carried out at Stanford Synchrotron Radiation Lightsource (SSRL) beamline 7-3 with an Si (220) double-crystal monochromator and a flat Rh-coated harmonic rejection mirror. Samples were maintained below 10 K with an Oxford Instruments liquid helium cryostat. Data were measured as fluorescence excitation spectra using a 30-element Ge array detector normalized to incident intensity measured with an N 2 -filled ion chamber. Data were measured with steps of 0.25 eV in the XANES region (1 s integration time) and 0.05 Å −1 in the EXAFS region to k = 13.5 Å − 1 (1-20 s integration, k 3 weighted). Energies were calibrated by assigning the lowest energy inflection point of a copper metal foil as 8,980.3 eV. An initial E 0 value of 9,000 eV was used to convert data to k-space, and the background was removed using a three-region cubic spline. EXAFS data were analyzed using EXAFSPAK (57) and FEFF 9.0 (58).
Visible Spectroscopy. The visible spectra of Cu(II)(TRIL23H) 3 200 mM MES buffer) . The visible spectra of Cu(II)(TRIL2WL23H) 3 (0.26 mM) at different pH conditions were collected in an unbuffered aqueous solution by adjusting the pH using small aliquots of concentrated KOH.
Binding Constants Determination. The affinity of (TRIL2WL23H) 3 for Cu(I) was determined by competitive binding assay with disodium bathocuproinedisulfonate (Na 2 BCS) as a competitive chelator in 50 mM aqueous buffer (MES, pH 5.9; Hepes, pH 7.4) (33). The affinity of TRIL2WL23H for Cu(II) was determined by monitoring the quenching of Trp fluorescence upon binding to Cu(II) in 50 mM buffered solutions (MES, pH 5.9; Hepes, pH 7.4). H NMR spectra were collected on a Varian MR400 spectrometer using gastight tubes where appropriate. The pH values were registered using Hamilton glass microelectrodes. The pH values in D 2 O were corrected using the formula reported in the literature (1) . [Cu(CH 3 CN) 4 ]BF 4 was purchased by Sigma-Aldrich, dissolved in degassed acetonitrile to obtain a stock solution ∼0.13 M, and standardized by spectrophotometric titrations using 2,9-dimethyl-1,10-phenantroline (2). IR spectra were collected on a Perkin-Elmer Spectrum BX FTIR spectrometer, using an NaCl window gas IR cell. UV-visible spectra were collected on a Varian Cary 100 UV-Vis spectrophotometer provided with a thermostat device, using matched quartz cells of 1 and 0.1 cm path length. EPR spectra were collected on a Bruker EMX X-band EPR spectrometer provided with a liquid nitrogen cryostat. Fluorescence spectra were collected on a Fluoromax-2 fluorimeter. X-ray absorption data analysis procedure. Single-and multiple-scattering fittings of extended X-ray absorption fine structure (EX-AFS) data were performed using EXAFSPAK (3) with ab initio amplitude and phase parameters calculated using FEFF 9.0 (4). X-ray absorption near-edge structure (XANES) data were normalized using EXAFSPAK. An initial model of Cu(I)-imidazole coordination was built based on the averaged bond distances reported for the crystal structures of synthetic molecules containing Cu(I)-imidazole constituent. Binding constants determination. The affinity of the (His) 3 site in the three-stranded coiled coils for Cu(I) and Cu(II) was determined using the peptide TRIL2WL23H, with a Leu substituted by Trp at position 2 of TRIL23H as a spectroscopic tag for concentration determination purposes (5) . The concentration of peptide stock solution was determined from Trp absorbance at 280 nm (5) . A solution of 40 μM Cu(I) and 80 μM (TRIL2WL23H) 3 was prepared in the glove box in aqueous 50 mM buffer (MES, pH 5.9; Hepes, pH 7.4) and titrated with bathocuproine disulfonate (BCS ; log β 2 = 19.8) (6) . The absorbance at 483 nm increased as BCS 2− was titrated into the Cu(I)-peptide solution. All titrant additions were carried out in the glove box. Specfit32 was used to fit the spectrophotometric data, taking into account the protonation equilibrium of BCS 2− at pH 5.9 (7).
A 500-800-nM solution of (TRIL2WL23H) 3 in 50 mM aqueous buffer (MES, pH 5.9; Hepes, pH 7.4) was titrated with 486 μM CuCl 2 solution, which was diluted from a 0.0486-M CuCl 2 solution, the concentration of which was confirmed by inductively coupled plasma optical emission spectroscopy. Upon each addition, the solution was stirred for 10 min to reach equilibrium and the fluorescence spectra were recorded. The apo-(TRIL2WL23H) 3 was titrated with the CuCl 2 solution up to Cu(II):apo-(TRIL2WL23H) 3 = 3. The affinity constants were obtained by treating the fluorescence spectra with Specfit32 (7), taking into account the formation of the Cu(II)/Hepes 1:1 complex (log β = 3.22) (8). Thein situ reductionofCu(II)(TRIL23H) 3 2+ into Cu(I)(TRIL23H) 3 + was monitored by addition of sodium ascorbate (0.565 μmol, 1 eq) to a 0.34-mM Cu(II)(TRIL23H) 3 2+ solution in deoxygenated 200-mM MES buffer (pH 6.0) obtained in 3 mL in a rubber-sealed quartz cuvette. The spectra were collected before and after ascorbate addition. Nitrite reductase activity. NO production. NaNO 2 stock solutions (∼0.5 mM) were prepared in 200 mM aqueous MES, pH 6.0, and added to the copper/peptide solution using a gastight syringe. A 0.01-M [Fe(EDTA)] 2− solution was prepared from FeSO 4 ·7H 2 O and H 2 EDTA in deoxygenated 1-M citrate aqueous buffer at pH 5.0. The latter solution (3 mL) was put in a rubber-sealed quartz cuvette, the spectrum was registered, and then the cuvette was connected to the reaction vial through a steel canula and kept in an ice bath at 0°C throughout the entire experiment. The reaction in the first solution was initiated by adding 1.13 × 10 ] (9). The control reaction was performed using an aqueous solution of [Cu(CH 3 CN) 4 ]BF 4 , at the same conditions described above. The production of NO starting from Cu(II)(TRIL23H) 3 2+ reduced in situ with ascorbate was performed using the same condition described above (200 mM MES, pH 6.0). CuCl 2 ·2H 2 O (1.13 mmol, ∼0.07 M in water) was added to the peptide, followed by sodium ascorbate (0.565 mmol). All solutions were prepared in a glove box.
Ascorbate oxidation in presence of nitrite. The turnover number (expressed as equivalents of electrons per equivalents of copper ions) for the oxidation reaction of ascorbate by nitrite in presence of Cu(II)(TRIL23H) 3 2+ as the catalyst was determined by UV spectroscopy at pH 5.9, monitoring the change in the absorbance of the ascorbate band at 265 nm. The variation of the concentration of ascorbate over time was calculated using the molar absorbance of ascorbate reported in the literature, taking into account the effective pH and a pK a of ascorbic acid of 4.02. A 2.4-mL solution containing (TRIL23H) 3 (0.30 mM) and sodium nitrite (31.6 mM) was prepared in the glove box using a degassed 200-mM MES solution in water. The pH was corrected to the desired value (5.8 or 5.9) by adding small aliquots of a concentrated KOH solution in degassed water. Aliquots (∼380 μL) of this solution were added with 20 μL of a Cu(II) chloride solution (∼3.8 mM) to obtain samples containing Cu(II) (0.180 mM), (TRIL23H) 3 (0.270 mM), and sodium nitrite (30 mM). The reaction of oxidation of ascorbate was started in the glove box by injecting ∼20 μL of a freshly prepared solution of sodium ascorbate in degassed water (21 mM) to obtain a final ascorbate concentration of ∼1.15 mM [corresponding to a 6.4-fold excess with respect to Cu(II)]. The solution was transferred into a rubber-sealed 0.1-cm path-length cuvette, and the UV spectrum (240-290 nm) collected every 5 min for 3-5 h total reaction time. The first spectrum was collected ∼10 min after ascorbate addition. The control samples containing only apo-peptide were prepared as reported above using a 90-μM peptide solution, by adding degassed water in place of the Cu(II) solution. This concentration corresponds to the excess of apo-peptide in the samples containing Cu(II)(TRIL23H) 3 2+ . The oxidation reaction in presence or absence of Cu(II) was monitored in triplicates. The turnover number (equivalent of electrons per moles of copper) was calculated as two times the average moles of ascorbate consumed in the sample containing Cu(II)(TRIL23H) 3 2+ subtracted by the moles of ascorbate consumed in the sample containing apo-(TRIL23H) 3 2+ divided by the moles of Cu(II). Additional control samples containing sodium nitrite (30 mM) in presence or absence of copper chloride (0.21 μM) added with sodium ascorbate (final concentration ∼1.15 mM) were prepared in a way similar to the one described above, and their spectra (240-290 nm) collected in triplicate every 5 min for 60 min. A 0.21-μM concentration of Cu (II) is ∼1.5 times the calculated amount of free Cu(II) at pH 5.9 in a sample containing the fully oxidized form of the peptide and a 50% excess of apo-peptide, based on the determined stability constants. The control of the stability of ascorbate in absence of nitrite was established by preparing samples containing Cu(II) (0.180 mM), (TRIL23H) 3 (0.270 mM), and sodium ascorbate (1.15 mM).
The rate of oxidation of ascorbate and the pseudo-first-order rate constants were calculated as described in SI Experimental Procedures, Calculations. The dependence of the reaction rate on the concentration of Cu(II)(TRIL23H) 3 2+ was studied in the 0.171-0.513-mM metallopeptide concentration. All samples contained a 0.5-eq excess of apo-peptide. Both samples and controls have been prepared as described above, and all contained 30 mM nitrite and ∼1.15 mM ascorbate. The control samples also contained a 0.085-0.257-mM apo-peptide corresponding to the excess of apo-peptide in the related metallopeptide samples. The spectra in the 240-290-nm range were collected every 3 min, and the samples run in triplicate. The pH dependence of the rate of oxidation of ascorbate in presence of Cu(II)(TRIL23H) 3 2+ was studied in the pH interval 5.3-6.5. The samples, prepared as described above, contained 0.180 mM copper chloride and 0.270 mM (TRIL23H) 3 (corresponding to a 0.180-mM Cu(II)(TRIL23H) 3 2+ and a 0.090-mM excess of apo-peptide), 30 mM sodium nitrite, and ∼1.15 mM sodium ascorbate. All samples were prepared in 200 mM MES buffer solution in water, and the pH was checked before adding the freshly prepared sodium ascorbate solution to initiate the reaction. The control samples all contained 0.090 mM apo-peptide, 30 mM nitrite, and ∼1.15 mM ascorbate.
Detection of N 2 O. A reaction mixture of 0.33 mM Cu(II)(TRIL2WL23H) 3 with 0.17-mM excess of apo-(TRIL2WL23H) 3 and 0.1 M NaNO 2 was prepared in the glove box with 50 mM phosphate buffer at pH 5.8 in a Schlenk flask. The reaction was initiated by injecting a stock solution of sodium ascorbate, preadjusted to pH 5.8. The final concentration of sodium ascorbate in the solution was 0.017 M. Control reaction was set up with 0.17 mM apo-(TRIL2WL23H) 3 , and all the other conditions were kept the same. The gas IR cell (10 cm, NaCl window) was vacuumed before connecting to the reaction flask. The IR spectra were collected on a Perkin-Elmer FTIR Spectrum BX instrument. Henry's law was used to calculate the distribution of the putative production of N 2 O in aqueous and gaseous phase. The Henry constant for N 2 O/water at room temperature was calculated based on ref. 10 . A calibration curve was made by diluting a series of N 2 O-saturated 50-mM phosphate buffer solution into the same reaction setup with the same headspace volume. The system was equilibrated for 1 h before connecting to the gas IR cell, and FTIR data were collected. The absorption peaks at 2,234.8 and 2,212.9 cm −1 were integrated. Based on the Beer-Lambert law, 3.30 × 10 −8 mol N 2 O was produced after 3.5 h, which is 0.09% of the amount of NO produced. Taking into account the instrument error, as well as pipetting errors during the dilution, we conclude that essentially no N 2 O was produced by the catalytic reaction during the process. is the absorbance at a given time t, A 0 640 nm the absorbance of the first collected spectrum (3 min after ascorbate addition), e Cu the molar absorbance of Cu(II)(TRIL23H) 3 2+ at the given pH and at 640 nm, and d the path length (1 cm). The molar absorbance e Cu has been established using the absorbance at 640 nm of the spectrum of the sample registered before adding ascorbate by the Cu (II) concentration.
The initial rate of oxidation of ascorbate (v Asc,ox ) for the reaction 1/2Asc − + Cu(II)(TRIL23H) 3 2+ = 1/2dH-Asc + Cu(I)(TRIL23H) 3 + + 1/2H + has been determined by monitoring the decrease of absorbance of ascorbate at 265 nm (dH-Asc = dehydroascorbate). All reactions were performed in triplicate. The dependence of the reaction rate on the concentration of Cu(II)(TRIL23H) 3 2+ (0.171-0.513 mM) was studied at pH 5.9. The turnover numbers have been calculated using the moles of ascorbate oxidized in the Cu(II)(TRIL23H) 3 2+ sample, corrected by the background reaction, monitoring the reactions for 3-5 h at pH 5.8 or 5.9. The turnover numbers, expressed as equivalents of electrons per equivalents of copper ions, were obtained by dividing the moles of ascorbate oxidized (after 220 min at pH 5.8, after 175 min at pH 5.9) by the moles of Cu(II) (TRIL23H) 3 2+ , and multiplying this value by two (ascorbate as two electron donor).
The rate of ascorbate oxidation has been calculated taking into account the absorbance values at 265 nm in the first 25 min after the collection of the first spectrum. The analysis of the absorption data ensured the linearity of the data as a function of time. 3 + and sodium nitrite (both 2.26 mM) in deoxygenated aqueous 200-mM MES buffer at pH 5.8. The thick line is the difference between the two spectra described above. 
